AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesA senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
The kiplinger letter spots trap emerges as a focal point in retirement planning as 401(K) plans weigh adding private ...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...
The S&P 500 has momentum, but not every stock is priced to perfection. These dividend stocks stand out for income...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A rising AI marketing startup secures a Nasdaq ticker and closes a financing round above $60 million, signaling stron...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
Huawei announces a new path to 1.4-nanometer chips by 2031, claiming it can close the gap with TSMC without EUV equip...
As Trump claims credit for the market surge, data shows Nvidia-led momentum dominates the gains and market breadth re...